Mirum (MIRM) Plunges 10%: A Brutal Intraday Washout or Deep Value Trap?

Summary

• Mirum Pharmaceuticals (MIRM) closed at $95.14, marking a sharp -10.07% daily decline.

• The stock opened at $90.25 and experienced high volatility, touching an intraday low of $88.88 before recovering slightly to close.

• Trading volume surged to 2,036,459 shares, with a turnover rate of 4.10%, signaling intense institutional and retail churn.

• The 52-week high stands at $130.00, while the 52-week low is $58.48, placing the current price in the lower third of its annual range.

Bearish Momentum Overrides Technical Support

The precipitous 10% drop in Mirum shares was driven by a complete collapse of short-term technical support structures. Despite opening near the day's low, the stock failed to sustain any meaningful upside momentum, sliding through the critical $95 psychological barrier. The absence of any specific company news or sector-wide catalyst suggests this move is a pure technical breakdown, likely triggered by algorithmic selling or profit-taking from holders who had accumulated positions near the 52-week highs. The heavy turnover indicates a significant transfer of chips from long-term holders to short-sellers or contrarian buyers, but the closing price near the lows confirms that bearish sentiment currently dominates the order flow.

Pharmaceutical Sector Resilience Contrasts with MIRM's Weakness

While Mirum suffered a severe drawdown, the broader Pharmaceutical sector displayed relative stability. Sector leader Pfizer (PFE) managed a modest gain of 0.79%, highlighting that the selling pressure on MIRM is idiosyncratic rather than systemic. This divergence suggests that institutional investors are rotating out of smaller-cap biotech names like Mirum while maintaining or increasing exposure to large-cap pharmaceutical giants with more stable cash flows. The lack of contagion in the sector underscores that Mirum’s decline is specific to its own valuation metrics or technical positioning, rather than a broader industry downturn.

Technical Breakdown Analysis and High-Leverage Option Plays

The technical landscape for Mirum is deeply concerning, with all major indicators flashing bearish signals in the short term. Key technical stats include:

• 200-Day Moving Average: 92.96 (Current Price Above: The stock is still technically in a long-term uptrend, but dangerously close to this critical support level.
• RSI (14): 31.17 (Approaching Oversold: The Relative Strength Index is nearing the 30 threshold, suggesting extreme selling pressure but also potential for a short-term bounce.
• MACD Histogram: -1.79 (Deeply Negative: The momentum oscillator is far below the signal line, confirming strong downward momentum.
• Bollinger Bands Lower: 101.64 (Price Below: The stock has shattered below the lower Bollinger Band, indicating a breakout to the downside.

The trading setup is precarious. The stock has broken below the 100-day moving average of $103.15 and is now testing the 200-day moving average at $92.96. A break below $92.96 could trigger a rapid slide toward the 200-day support zone of $69.25–$70.54. Conversely, a recovery above $97.00 (intraday high) is needed to validate any short-term reversal. Given the lack of leveraged ETF data, the focus shifts entirely to options strategies that capitalize on volatility or directional moves.

Based on the options chain, the following two contracts stand out for their leverage and liquidity characteristics:

1. MIRM20260821P90 (Put Option)

   • Strike: $90 | Expiration: 2026-08-21 | Volume: 26 | Turnover: 5,049 | IV Ratio: 41.90% | Delta: -0.23 | Theta: -0.01 | Gamma: 0.04 | Leverage: 79.45%

This contract offers high gamma (0.04), meaning its price is highly sensitive to underlying stock movements, and a moderate leverage ratio of 79.45%. The turnover of 5,049 indicates it is the most liquid put option available, ensuring easy entry and exit. The delta of -0.23 provides a balanced risk-reward profile for a bearish bet, while the IV ratio of 41.90% is reasonable, avoiding the extreme pricing of out-of-the-money options.

1. MIRM20260821C90 (Call Option)

   • Strike: $90 | Expiration: 2026-08-21 | Volume: 3 | Turnover: 1,977 | IV Ratio: 49.65% | Delta: 0.73 | Theta: -0.28 | Gamma: 0.03 | Leverage: 13.22%

While volume is lower, this call option has a high delta of 0.73, making it behave almost like the stock itself, and a strong gamma of 0.03. The turnover of 1,977 provides sufficient liquidity for smaller positions. The IV ratio of 49.65% is mid-range, and the theta decay of -0.28 is significant, indicating this is a short-term trade that requires quick movement. It is suitable for traders betting on a sharp bounce above $95.

Options Payoff Calculation Primer: For this payoff estimation, we assume a 5% downside scenario from current price (95.14) where for Call Option Payoff = max(0, ST - K) where ST is projected price and K is strike price and Put Option Payoff = max(0, K - ST) where ST is projected price and K is strike price. This projection helps evaluate option contracts' potential returns under a bearish move scenario.

If $92.96 breaks, MIRM20260821P90 offers aggressive short-side potential with high gamma exposure. Aggressive bulls may consider MIRM20260821C90 only into a confirmed bounce above $97.00.

Watch the $92.96 Lifeline or Prepare for a Deeper Correction

The current move in Mirum is a technical breakdown rather than a fundamental shift, but the proximity to the 200-day moving average at $92.96 makes it a critical juncture. Investors should watch for a decisive break below $92.96, which would likely accelerate selling toward the $70 support zone. Conversely, a sustained hold above this level could lead to a relief bounce. While sector leader Pfizer (PFE) gained 0.79%, highlighting sector strength, Mirum remains under pressure. Action-oriented insight: Monitor the $92.96 support level closely; a break below it signals further downside, while a hold invites speculative long positions.